Xcout Intel
DIASORIN competitors & alternatives
The 12 closest competitors and alternatives to DIASORIN among biotech companies — ranked by similarity to what DIASORIN actually does, not by market-cap band.
Subscribe to see DIASORIN’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About DIASORIN
Diasorin S.p.A. is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics and since July 2021, it is also active in the Life Science business. The group was founded in 2000 and is headquartered in Saluggia, Italy. Its production is at several plants located in Europe and the United States: Saluggia and Gerenzano (Italy), Dietzenbach (Germany), Stillwater, Minnesota (US), Dartford (UK). Following the acquisition of Luminex, the company acquired five additional production plants located in th
DIASORIN at a glance
DIASORIN is a biotech company headquartered in Italy. Xcout tracks 2 named people at DIASORIN, including Gustavo Denegri (Owner).
DIASORIN leadership
- Gustavo DenegriOwner
- Gustavo DenegriChairman
Top 12 DIASORIN competitors
Ranked by semantic similarity — how close each company is to DIASORIN by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Trinity Biotech plc, an Irish enterprise founded in 1992 and headquartered in Bray, is engaged in the acquisition, development, manufacturing, and global distribution of medical diagnostic solutions. The company's reach extends to the Americas, Africa, Asia, and Europe, catering to both clinical laboratory and point-of-care diagnostic markets. Its extensive range of clinical laboratory offerings encompasses diagnostic tests and specialized instrumentation for identifying numerous infectious diseases. These include Lyme disease, sexually transmitted infections like syphilis and herpes, SARS-CoV-2, and a variety of viral pathogens such as Epstein Barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, and varicella. Additionally, Trinity Biotech provides in-vitro diagnostic products centered on haemoglobin A1c for the crucial monitoring, diagnosis, and risk assessment of diabetes. The company's product development incorporates diverse assay formats, including immunofluorescence, enzyme-linked immunosorbent (ELISA), Western blot, and line immunoassays. It also supplies a suite of reagent products, including ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase, vital for diagnosing liver and kidney disorders, as well as haemolytic anaemia. Beyond diagnostics, Trinity Biotech serves the life sciences industry and research facilities by supplying raw materials. The company's customer base comprises public health authorities, non-governmental organizations, and both clinical and reference laboratories. Its products are distributed through a dedicated direct sales force, complemented by a broad network of independent distributors and strategic partnerships.
Clinical Diagnostics
Instrumentation Laboratory (IL) is a clinical diagnostics company that develops and manufactures hemostasis, critical care, and blood-gas testing systems and related reagents. Its products serve hospitals, clinical laboratories, and other healthcare providers; the company is part of Werfen and has an Italian operating entity.
Similar biotech company
Novacyt S.A., together with its associated entities, specializes in the research, production, contract design, and market launch of diagnostic solutions. These offerings are primarily developed for the detection of cancer and a range of infectious diseases. The company maintains an extensive international operational footprint, encompassing the United Kingdom, the broader European continent, the United States, the Asia Pacific region, the Middle East, and Africa. Its operations are segmented into three core divisions: Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment is dedicated to the conceptualization, manufacturing, and commercialization of molecular real-time qPCR testing equipment and corresponding reagents, specifically for infectious disease diagnostics. The Lab21 Products division focuses on the development, production, and supply of various protein-based in-vitro diagnostic (IVD) devices that target infectious illnesses. Meanwhile, IT-IS International is responsible for engineering and fabricating PCR devices utilized within both the life sciences and food testing industries. Novacyt serves a diverse client base, including healthcare institutions and corporate organizations. The company was established in 2006 and is headquartered in Vélizy-Villacoublay, France.
Medical Diagnostics
HUMAN Diagnostics Worldwide is a German manufacturer and supplier of in vitro diagnostic equipment, reagents, and laboratory solutions for clinical diagnostics.
Biotechnology
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Medical Diagnostics
EUROIMMUN is a global manufacturer of test systems and automation solutions for medical laboratory diagnostics, specializing in autoimmune, infectious, and neurological diseases.
Similar biotech company
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Biotechnology
Innogenetics was a Belgian biotechnology company headquartered in Ghent that developed molecular diagnostic products for infectious diseases. It was known for hepatitis C genotyping and related immunoassays, serving clinical laboratories and healthcare providers; the company was later acquired by Fujirebio.
Similar biotech company
Getein Biotech, Inc. is an enterprise primarily focused on the research, development, manufacturing, and global distribution of in vitro diagnostic (IVD) solutions. Founded in 2002 and based in Nanjing, China, the company offers a comprehensive array of diagnostic products. This includes a variety of diagnostic reagents, advanced analytical instruments, and crucial calibrators. Getein also supplies foundational raw materials for reagents, such as monoclonal and polyclonal antibodies, antigens, antiserum, and microspheres. Its extensive product line caters to diverse medical fields, encompassing diagnostics for cardiac markers, inflammatory conditions, renal function, blood coagulation, thyroid disorders, fertility assessments, diabetes care, and thrombus detection. These offerings broadly serve applications in cardiovascular, inflammatory, diabetes, reproductive, renal, hepatic, and other key health areas.
Medical Diagnostics & Healthcare
Sysmex Europe provides medical diagnostic equipment, reagents, and IT solutions for laboratories, healthcare facilities, and life science research.
Medical Diagnostics
Immy Inc. develops, manufactures, and distributes diagnostic tests, reagents, and processing systems specializing in mycology. The company serves healthcare professionals, reference laboratories, and hospital settings by providing lateral flow assays, enzyme immunoassays, and PCR tests for the detection of fungal diseases.
Similar biotech company
Eurofins Scientific SE is a French group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental, agriscience and consumer products industries and to governments.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of DIASORIN and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for DIASORINand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →